bionomics

Biotechs stall as risk appetite fades

Brian RobinsWhat a difference a year makes. The downturn in mining stocks from 2013 saw hot money flow into the biotech sector. But after some spectacular research failures, sentiment soured, leaving the sector firmly in the shadows for much of 2014 so that even the surge in biotech stocks globally bypassed the local players.Alchemia, QRx Pharma and Prana were all […]